Contains fulltext : 233485.pdf (Publisher’s version ) (Closed access
Coronavirus disease 2019 (COVID-19) has a wide spectrum of clinical manifestations. An elevation of ...
Following the SARS-CoV-2 outbreak and the subsequent development of the COVID-19 pandemic, organs su...
While respiratory symptoms are prevalent in SARS-CoV-2 infected patients, growing evidence indicates...
Introduction: The severity of COVID-19 may be correlated with the risk of liver injury development. ...
Introduction. Major cardiovascular and pulmonary comorbidities, as well as diabetes mellitus and cer...
Remdesivir is one of the effective anti-viral drugs used as a Covid-19 therapy at moderate, severe a...
The coronaviruses that cause notable diseases, namely, severe acute respiratory syndrome (SARS), mid...
COVID-19 (coronavirus disease 2019, a disease caused by a new coronavirus 2019) continues to threa...
International audienceObese patients who often present metabolic dysfunction-associated fatty liver ...
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus...
Remdesivir has demonstrated clinical benefits in randomized placebo-controlled trials (RCTs) in pati...
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China...
Drug-Induced liver injury (DILI) is a common harmful drug reaction of some medication which can caus...
The global outbreak of COVID-19 possesses serious challenges and adverse impacts for patients with p...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted the world and caused the 2...
Coronavirus disease 2019 (COVID-19) has a wide spectrum of clinical manifestations. An elevation of ...
Following the SARS-CoV-2 outbreak and the subsequent development of the COVID-19 pandemic, organs su...
While respiratory symptoms are prevalent in SARS-CoV-2 infected patients, growing evidence indicates...
Introduction: The severity of COVID-19 may be correlated with the risk of liver injury development. ...
Introduction. Major cardiovascular and pulmonary comorbidities, as well as diabetes mellitus and cer...
Remdesivir is one of the effective anti-viral drugs used as a Covid-19 therapy at moderate, severe a...
The coronaviruses that cause notable diseases, namely, severe acute respiratory syndrome (SARS), mid...
COVID-19 (coronavirus disease 2019, a disease caused by a new coronavirus 2019) continues to threa...
International audienceObese patients who often present metabolic dysfunction-associated fatty liver ...
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus...
Remdesivir has demonstrated clinical benefits in randomized placebo-controlled trials (RCTs) in pati...
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China...
Drug-Induced liver injury (DILI) is a common harmful drug reaction of some medication which can caus...
The global outbreak of COVID-19 possesses serious challenges and adverse impacts for patients with p...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted the world and caused the 2...
Coronavirus disease 2019 (COVID-19) has a wide spectrum of clinical manifestations. An elevation of ...
Following the SARS-CoV-2 outbreak and the subsequent development of the COVID-19 pandemic, organs su...
While respiratory symptoms are prevalent in SARS-CoV-2 infected patients, growing evidence indicates...
DOI
Add to ORKG